Dr. Janet S Segall, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 90 Shenango St, Greenville, PA 16125 Phone: 724-588-4240 Fax: 724-588-0198 |
Ms. Margaret Jo Browning, C.N.M. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 74 Shenango St, Greenville, PA 16125 Phone: 724-588-2272 Fax: 724-588-4187 |
Megan M Schreiber, PA-C Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 90 Shenango St, Greenville, PA 16125 Phone: 724-588-4240 Fax: 724-588-0198 |
Dr. David L Mcfadden, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 90 Shenango St, Greenville, PA 16125 Phone: 724-588-4240 Fax: 724-588-0198 |
News Archive
An internationally recognized expert in viruses, Robert W. Finberg, MD, the Richard M. Haidack Professor of Medicine and chair and professor of medicine at the University of Massachusetts Medical School, is lead investigator on a $12 million project to develop new ways of predicting how the influenza virus changes and evolves in response to anti-viral drugs and the human immune system. This approach has promise for becoming a pivotal tool in creating a more effective vaccine against the virus.
"Insecticide-treated bednets, whose use is being widely promoted in Africa to combat malaria, may paradoxically be linked to local resurgence of the disease," according to a study published in the Lancet on Thursday, the Independent reports.
New research suggests that saffron provides a significant chemopreventive effect against liver cancer in animal models. When saffron was administered to rats with diethylnitrosamine (DEN)-induced liver cancer an inhibition of cell proliferation and stimulation of apoptosis was observed. Full findings appear in the September issue of Hepatology, a journal published by Wiley Blackwell on behalf of the American Association for the Study of Liver Diseases.
Appistry, Inc., a leading provider of tools, software, and services that bring the power of genomics to next-generation medicine, today announced an agreement with Personal Genome Diagnostics (PGDx) to include the company's CancerSelect™ panel in Appistry's recently released Appistry CloudDx™ genomics testing service.
› Verified 7 days ago